Botanix Pharma is developing therapeutics for the treatment of serious skin diseases.
60° Pharmaceuticals (60P) was founded in 2010 to treat tropical diseases
Advanced Accelerator Applications (AAA) develops, produces and commercializes molecular nuclear medicine, diagnostic and therapeutic products in the fields of oncology (cancer), neurology, ...
Develops the AYX platform, a proprietary technology of non-opioid, disease-modifying transcription factor decoys. AYX decoys are short DNA molecules, or oligonucleotides, that selectively inhibit ...
Custom Proteoglycan Therapies
Akcea is developing treatments for unaddressed or under-addressed serious and rare diseases with leading-edge, RNA-targeted medicines.
Akero Therapeutics is providing treatment options for people with serious metabolic diseases like non-alcoholic steatohepatitis (NASH), a disease marked by inflammation in the liver and liver cell ...
Developing drugs to treat pain
AM–Pharma is a biopharmaceutical company developing proprietary recombinant human Alkaline Phosphatase (AP) therapeutics, which have the potential to transform the treatment prospects for patients ...
AMAG is a pharmaceutical company focused on treating anemia, pregnancy complications, women’s sexual function and menopause-related issues
Aminex Therapeutics, Inc., is a drug development company focused on discovery and development of a unique cancer drug therapy in the general category of cancer immunotherapies known as checkpoint ...
Developing translation control therapeutics, a new class of drugs that specifically control protein translation
Apellis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition of the complement system, ...
Arbutus Biopharma Corporation (NASDAQ: ABUS) is a publicly-traded biopharmaceutical company dedicated to discovering, developing ...
Arcturus Therapeutics Ltd. is a preclinical-stage biopharmaceutical company primarily focused on the discovery, development and commercialization of RNA medicines using proprietary lipid-mediated ...
Developing PRDM Gene and Protein Modulation Agents as Anti-Cancer Products
Relaxin hormone antagonists
Artemis Therapeutics, Inc. (ATMS) is a biopharmaceutical company developing novel treatments for serious and life-threatening infections.
Developing therapeutics to address neurological disabilities like Alzheimers disease and Downs Syndrome.
Biohaven is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders.
Develops antibody-based therapeutics
Therapeutics & Diagnostics targeting nf-P2X7
Founded in February 2018, Biothus is a pharmaceutical company, focused on antibody-based drugs to deal with cancer, immunotherapy and metabolic diseases.
Bioventus is a global leader in orthobiologics. Through a combination of internal product development, product/business acquisition, and distribution agreements, we will bring to market products ...
Bioverativ will be an independent, publicly-traded, global biotechnology technology focused on the discovery, research, development and commercialization of therapies for hemophilia and other ...
Blade Therapeutics is advancing novel anti-fibrotic therapies to meet important patient needs in an area that has seen little innovation to date.
Blade Therapeutics is advancing novel anti-fibrotic therapies to meet important patient needs in an area that has seen little innovation to date
A biopharmaceutical company. They discover, develop, and deliver medicines to treat serious disease.
CAMP4 has built a proprietary 4-D Gene Circuity Platform to codify the discrete set of combinatorial rules used by any human cell type central to disease pathology.
Cancer Drug Discovery and Technology Transfer
Cannabis Biotech conducts research to develop innovative cannabinoid products and therapies for the treatment of diseases and their symptoms. Ailments that the company has studied include HIV, ...
Working to develop novel cannabinoid-based therapies.